Innovent Biologics, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
-40.00
-1,264.00
-2,523.00
-3,183.00
-964.00
-1,950.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
437.00
445.00
360.00
-110.00
-375.00
-160.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
1,978.00
360.00
-2,228.00
-2,352.00
-260.00
-1,854.00
Cash Flow from Investing Activities
-2,763.00
-1,508.00
-2,035.00
-2,227.00
-5,880.00
-2,993.00
Cash Flow from Financing Activities
-524.00
2,999.00
3,485.00
6,125.00
5,571.00
2,438.00
Net Cash Inflow / Outflow
-1,295.00
1,844.00
-641.00
1,307.00
-1,209.00
-2,380.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
13.00
-7.00
137.00
-237.00
-639.00
28.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Innovent Biologics, Inc.
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
-40.7798271642751
5513.47556787416
-5,553.00
-100.74%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
437.76079753036
39.2087868164863
398.00
1016.49%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
1978.77681867259
5133.83675786894
-3,155.00
-61.46%
Cash Flow from Investing Activities
-2763.53586742958
-2458.67055472267
-305.00
-12.40%
Cash Flow from Financing Activities
-524.988774107523
-6573.36509045738
6,049.00
92.01%
Net Cash Inflow / Outflow
-1295.99769609388
-3965.88698179867
2,670.00
67.32%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
13.7501267706407
-67.6880944875491
80.00
120.31%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is 448.47% vs 116.19% in Dec 2023
Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
1,978.78
360.78
448.47%






